Watershed Asset Management, L.L.C. Innoviva, Inc. Transaction History

Watershed Asset Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $23,904 - $31,337	2,059 Added 11.39%	20,135 $234,000
Q2 2022 Aug 05, 2022	BUY	$14.32 - $19.88 $39,422 - $54,729	2,753 Added 17.97%	18,076 $267,000
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $7,833 - $10,307	-509 Reduced 3.22%	15,323 $297,000
Q4 2021 Feb 11, 2022	BUY	$15.91 - $18.72 $251,887 - $296,375	15,832 New	15,832 $273,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Watershed Asset Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Watershed Asset Management, L.L.C. with notifications on news.